Center for Vaccine Innovation

Overview

Modern medicine has made tremendous strides in fighting infectious diseases, but there is much more work to be done. Every year, influenza strikes millions of people, many of them fatally. Whooping cough and measles have made a comeback as the number of people who refuse to vaccinate their children grows. One third of the world’s population is infected with latent tuberculosis. Without treatment, about 5 to 10 percent of infected people will develop TB disease at some time in their lives.

Coronavirus Task Force

Meanwhile, the SARS-CoV-2 pandemic is sweeping the globe, taking the lives of hundreds of thousands. La Jolla Institute, one of the leading global organizations dedicated to studying the immune system, is stepping up to provide much needed information and real solutions for the ongoing COVID-19 pandemic. We have launched a multi-lab Coronavirus Task Force that capitalizes on our competitive advantages of unique skill in infectious disease research, state-of-the-art technology and highly collaborative organization to respond to the current crisis and prepare for future emerging diseases. Our other work on HIV, Ebola, Dengue, Zika, and Cytomegalovirus are further laying the groundwork for developing vaccines for these serious infections.

Mission

THE VISIONARIES

LIFE WITHOUT DISEASE

Related Diseases

Labs

Christopher Benedict, Ph.D.

Associate Professor

Michael Croft, Ph.D.

Director, Academic Affairs

Shane Crotty, Ph.D.

Professor & Chief Scientific Officer

Tal Einav, Ph.D.

The Bodman Family Assistant Professor

Alba Grifoni, Ph.D.

Research Assistant Professor

Mitchell Kronenberg, Ph.D.

Professor, President Emeritus

Bjoern Peters, Ph.D.

Professor

Erica Ollmann Saphire, Ph.D., MBA

Professor, President & Chief Executive Officer

Benjamin Schmiedel, Ph.D.

Research Assistant Professor

Stephen Schoenberger, Ph.D.

Professor

Alessandro Sette, Dr.Biol.Sci.

Professor

Sujan Shresta, Ph.D.

Professor

Daniela Weiskopf, Ph.D.

Assistant Professor

Related News

LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
LJI and Synbal, Inc. scientists develop new tool for pandemic preparedness
Shresta and her LJI colleagues work toward pandemic preparedness as members of the national 'ReVAMPP' network
San Diego laboratories lead vaccine innovation research through new ARPA-H program
Scientists capture first look at key viral structure within infected host cells
New LJI research suggests many people already have T cells with the power to fight "highly pathogenic" avian influenza

Selected Publications

Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, Burger ZC, Rawlings SA, Smith DM, Phillips E, Mallal S, Lammers M, Rubiro P, Quiambao L, Sutherland A, Yu ED, da Silva Antunes R, Greenbaum J, Frazier A, Markmann AJ, Premkumar L, de Silva A, Peters B, Crotty S, Sette A, Weiskopf D.
Grifoni, A., Weiskopf, D., Ramirez, S.I., Mateus, J., Dan, J.M., Moderbacher, C.R., Rawlings, S.A., Sutherland, A., Premkumar, L., Jadi, R.S., Marrama, D., de Silva, A.M., Frazier, A., Carlin, A., Greenbaum, J.A., Peters, B., Krammer, F., Smith, D.M., Crotty, S., Sette, A.,
Dan JM, Havenar-Daughton C, Kendric K, Al-Kolla R, Rosales SL, Anderson EL, LaRock CN, Vijayanand P, Seumois G, Layfield D, Cutress RI, Ottensmeier CH, Lindestam Arlehamn CS, Sette A, Nizet V, Bothwell M, Brigger M, Crotty S
Hastie KM, Cross RW, Harkins SS, Zandonatti MA, Koval AP, Heinrich ML, Rowland MM, Robinson JE, Geisbert TW, Garry RF, Branco LM, Saphire EO
Wen J, Elong Ngono A, Regla-Nava JA, Kim K, Gorman MJ, Diamond MS, Shresta S
Aug 17, 2016

Zika virus infects neural progenitors in the adult mouse brain and alters proliferation

Li H, Saucedo-Cuevas L, Regla-Nava JA, Chai G, Sheets N, Tang W, Terskikh AV, Shresta S, Gleeson JG

Support Life Without Disease

Join a Study

Connect